SGMO Sangamo Therapeutics Inc

$SGMO and I are working everyday, along with all other equity committee members, to create value and do best by equity and for equity. Info will be released publicly at the appropriate time and hopefully sooner rather than later. This has been a tremendous obligation on our time for which we are being paid nothing. Best regards all.

$SGMO My post on X showing how valuable Sangamo France actually is to Sangamo equity holders. With a 4.7 mil euro payment due this month, they should have almost $10 mil, minus around 25-50k a month for OE, rough estimate as SF is just being kept open for tax purposes.....

$SGMO I just posted my updated Equity Waterfall on X since we had the Claims Register filing as of Oct 5, and the August MOR......

$SGMO Well folks, being stuck in the Expert Market absolutely sucks, but it doesn't change my equity waterfall analysis or my outlook on potential shareholder recovery. Personally, I hate being limited to selling only in such an unbalanced, illiquid market. The flexibility to buy additional shares on positive news or sell/trim a position when necessary has been severely compromised. Unfortunately, this is one of the risks of investing in a company navigating Chapter 11 bankruptcy. That said, the underlying assets, potential milestone payments, and remaining liabilities haven't suddenly changed because of this trading restriction. For me, the focus now shifts back to what really matters: the upcoming Chapter 11 reorganization plan, remaining asset sales, and ultimately what value can be preserved for existing shareholders. Frustrating? Absolutely. But my investment thesis remains unchanged.

$SGMO it must be chiselled in our minds that the current share price does not reflect at all the value of the estate in the Ch11 case. I had some margin calls Friday when the price dropped to $.06 so was forced to convert some £ to $... but I am still here with my 79k shares at $.21 I am good at waiting, I am very resilient, bt I'll see the end of this one! For many years I've traded Sangamo, made money lost money, it's the nature of this game.

$SGMO as if we didn’t know already, I think it’s abundantly clear that mgmt is actively trying to harm shareholders. Hope they get exposed and incur whatever wrath the justice system can impose on them.

$SGMO Okay, here are my current thoughts. The new plan sponsor is coming. The plan is expected to be released in October. The sponsor would need to bring in roughly 60–80 million—which is essentially the amount that should remain as pure cash. I also believe that no other company will be integrated into the shell, given that there is still a revolutionary program in the form of ST-503. I think a buyout could follow a relisting on the Nasdaq; it depends on what the ST-503 data shows.

$SGMO Neither the EC nor the judge can or will approve a deal that leaves common equity worse off than a straight liquidation. Under US bankruptcy law, this is protected by the "Best Interests Test" (Section 1129(a)(7) of the Bankruptcy Code). The judge is legally barred from confirming a Plan of Reorganization if the equity class would receive less than they would in a hypothetical Chapter 7 cash liquidation. Since our baseline liquidation value is already a massive pile of cash ($75M+) plus the Fabry APA rights, any Plan Sponsor stepping in to take the shell and the NOLs MUST offer a combined package (Upfront Cash + CVRs + Stub Equity) that mathematically beats that baseline. If the Sponsor's offer was worse, the EC would have walked away weeks ago, and the judge wouldn't even entertain the discussion. The entire setup points to a massive increase in value for existing shareholders. I increased my position again today. Perhaps we underestimated something there…

$SGMO always thought Nav 1.7 was the most promising and showed the most interest by BP. Maybe the delay means some interest. It’s amazing to see how greedy Co’s are even with Trillion $ market caps. Why not make a fair offer, that has some moral backing? Is Sandy still getting his million $ consulting job for $LLY ? He did such a good job for them, at the expense of his shareholders.

$SGMO In fact, the intrinsic value has likely increased, given the pending auctions and the potential monetization of the public shell company. I also believe that the hemophilia program will find a buyer. Anyone selling now is beyond help. The "Expert Market" enforces the patience required until the payout occurs… In my view, Grekko’s "waterfall" calculations are actually on the conservative side…

$SGMO Just posted on Sangamo website: ST-520 is finally going to auction!!! In my mind, that pretty much confirms a sale with proceeds to be distributed, not a re-float. Expected to be completed in 4Q

$SGMO can't help but wonder if our fellow shareholders representing us on the committee have been sucked into the morass that is SGMO - would love to see some sort of timeline commitment - that we used to have - in terms of court dates - now - no idea when this is going to be put to bed and/or if there is SGMO - part 2 - which i wholeheartedly vote NO on - btw - please lets get this done - please put out next steps and a timeline - this is way overdue to be done - it's mid - october - this was supposed to be done early to mid - September

$SGMO I defended Sandy for a long time, but this Chapter 11 has completely changed my view. Management has handled this terribly and bears a major share of the blame for destroying shareholder value. In my opinion, the Equity Committee is the main reason common shareholders still have a real chance of a meaningful recovery.

$SGMO RBC says $PTCT looking for more deals , also in #CNS so maybe $PTCT will also be a bidder for $SGMO NAV1.7 ....

$SGMO I know logically and risk mgmt wise I shouldn’t buy anymore because I’m already loaded up, but man oh man I’m really itching to buy more while it stays around .14. Just hard to imagine its worth any less than current price, and 2x upside looks soooo locked in. Even 3x isnt out of question. What to do? What to do?

$SGMO I calculate a cash position of 110 million by the end of August—roughly 0.26 dollars per share. Base is the MOR Report from August

$SGMO Just had a nice dream… We weren’t just paid out and sent home. The negotiations resulted in a cash payout, plus future milestone rights, plus shares in the new tax-shield entity. That’s exactly why the EC took its time—they were structuring the ultimate hybrid exit. And then, unfortunately, I woke up… but who knows?

$SGMO $SGMO on the "expert market now " ... Quotations in Expert Market securities are restricted from public viewing manipulation trades so far this morning 1 cent to .143 volume 100K only value still at least .25 .50 with Fabry approval date set for omnibus hearing december15

$SGMO The market has not yet factored in the new docket at all; this is a fundamental point. Consequently, it is fairly certain that the net cash value per share lies between $0.20 and $0.25. The docket lists all claims, which total a maximum of $45 million. It is crucial to note that some items are listed twice. The list also includes bonus payments. So, the only additional costs to consider are legal fees and the FSI loan, which will not be fully drawn down.

$SGMO Of my three brokers, I was only able to buy SGMOQ through IBKR. As of today, even with this broker, only selling is possible. I wonder—who is doing the buying, then?